Series A - Avenzo Therapeutics
Investment Firm
Overview
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
Announced Date
Mar 26, 2024
Closed on Date
Mar 26, 2024
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
New Enterprise Associates
New Enterprise Associates is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and venture firm.
Sands Capital Ventures
Sands Capital Ventures is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.
Sofinnova Investments
Sofinnova Investments is a early_stage_venture and late_stage_venture and post_ipo and venture firm.
Deep Track Capital
Deep Track Capital is a post_ipo and private_equity firm.
Participant Investors
7
Round Details and Background
Avenzo Therapeutics raised $150000000 on 2024-03-26 in Series A
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 26, 2024 |  Series A - Avenzo Therapeutics | 8 | - | 150.0M |
| May 26, 2023 | Venture Round - Avenzo Therapeutics | 2 | - | 196.0M |
| Sep 27, 2022 | Venture Round - Avenzo Therapeutics | - | 223.4M |
Recent Activity
There is no recent news or activity for this profile.